Vivos Therapeutics (VVOS) Share-based Compensation Growth (3y) (2023 - 2026)
Vivos Therapeutics (VVOS) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 0.56% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 13.40% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | - |
| 10 | Vivos Therapeutics | 5.89 Mn | 3.78 Mn | 3.06 Mn | 104.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.06% |
| Dec 31, 2025 | -51.95% |
| Sep 30, 2025 | 91.29% |
| Jun 30, 2025 | -24.61% |
| Mar 31, 2025 | -19.56% |
| Dec 31, 2024 | -66.41% |
| Sep 30, 2024 | -35.15% |
| Jun 30, 2024 | 132.08% |
| Mar 31, 2024 | -12.27% |
| Dec 31, 2023 | -37.00% |
| Sep 30, 2023 | -22.44% |
| Jun 30, 2023 | -10.89% |
| Mar 31, 2023 | 17.74% |